Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05830968 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne
A NA study of Inflammatory Acne Vulgaris, sponsored by InMode MD.
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 4
- Study locations
NCT05830968 is a NA study of Inflammatory Acne Vulgaris that is actively recruiting participants, run by InMode MD. The registered enrollment target is 42 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT05830968, a NA study of Inflammatory Acne Vulgaris, is actively recruiting participants, sponsored by InMode MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 4
- Study locations
Study Summary
The aim of this trial is to evaluate the safety and efficacy of the InMode RF Pro System with the Morpheus8 face tip (24 pins) applicator for the treatment of mild, moderate and severe, facial acne vulgaris
Conditions Studied
Interventions
- DEVICE Morpheus8 Applicator Radiofrequency device
Study Locations (4)
Arizona
- Avant Dermatology Aesthetics - Oro Valley
Colorado
- AboutSkin Research, LLC - Greenwood Village
New York
- UnionDerm - New York
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05830968
The ClinicalTrials.gov registry entry for NCT05830968 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InMode MD, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inflammatory Acne Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which Morpheus8 Applicator Radiofrequency device is the first listed.
NCT05830968 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Colorado, New York.
Frequently Asked Questions
What is clinical trial NCT05830968 about?
NCT05830968 is a clinical study titled "Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne". The aim of this trial is to evaluate the safety and efficacy of the InMode RF Pro System with the Morpheus8 face tip (24 pins) applicator for the treatment of mild, moderate and severe, facial acne vulgaris
What is the current status of trial NCT05830968?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2023-05-01. Estimated completion is 2026-05-01.
What conditions does trial NCT05830968 study?
This clinical trial studies the following conditions: Inflammatory Acne Vulgaris.
What interventions are being tested in trial NCT05830968?
The interventions under investigation include: Morpheus8 Applicator Radiofrequency device (DEVICE).
Who is sponsoring clinical trial NCT05830968?
This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05830968 being conducted?
This trial has 4 study locations across Arizona, Colorado, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.